Dr.Senthil Advanced Science (Opc) Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth 711.06%
- Profit Growth 1819.65%
- Ebitda 3580.12%
- Net Worth 683.08%
- Total Assets 113.25%
About Dr.Senthil Advanced Science (Opc)
Dr.Senthil Advanced Science (Opc) Private Limited (DASOPL) is a registered startup operating as a Company incorporated in India on 03 May 2019 (Five years and nine months 24 days old ). Its registered office is in Cuddalore, Tamil Nadu, India.
The Company is engaged in the Aquaculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Senthilkumar Arumugam serves as a director at the Company.
Company Details
- Location
Cuddalore, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U05000TN2019OPC129097
- Company No.
129097
- Incorporation Date
03 May 2019
- Date of AGM
-
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Dr.Senthil Advanced Science (Opc)?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Senthilkumar Arumugam  | Director | 03-May-2019 | Current |
Financial Performance of Dr.Senthil Advanced Science (Opc).
Dr.Senthil Advanced Science (Opc) Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 711.06% increase. The company also saw a substantial improvement in profitability, with a 1819.65% increase in profit. The company's net worth Soared by an impressive increase of 683.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr.Senthil Advanced Science (Opc)?
Unlock access to Dr.Senthil Advanced Science (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Dr.Senthil's Hiqu Foods Private LimitedSenthilkumar Arumugam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr.Senthil Advanced Science (Opc)?
Unlock and access historical data on people associated with Dr.Senthil Advanced Science (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.Senthil Advanced Science (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Senthil Advanced Science (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.